Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 47
Page 14
... respiratory cancer. Environmental Health Perspectives, 70, 51–56. Reddy, A. (2000, October 22). Non-small cell lung cancer: Imaging and staging. Paper presented at the 42nd an- nual meeting of the American Society for Therapeutic ...
... respiratory cancer. Environmental Health Perspectives, 70, 51–56. Reddy, A. (2000, October 22). Non-small cell lung cancer: Imaging and staging. Paper presented at the 42nd an- nual meeting of the American Society for Therapeutic ...
Page 15
... Respiratory Diseases, 92(5), 758–766. Travis, W., Colby, T., Corrin, B., Shimosato, Y., Brambilla, E., Sobin, L., et al. (1999). Histological typing of lung and pleural tumors (3rd ed.). New York: Springer-Verlag. Judy R. Prewitt ...
... Respiratory Diseases, 92(5), 758–766. Travis, W., Colby, T., Corrin, B., Shimosato, Y., Brambilla, E., Sobin, L., et al. (1999). Histological typing of lung and pleural tumors (3rd ed.). New York: Springer-Verlag. Judy R. Prewitt ...
Page 18
... respiratory epithelium. This same technology is enabling researchers to examine the thousands of genes in individual lung cancers, which has demonstrated congruence between the histological and clinical presentation (Fong, et al., 2003) ...
... respiratory epithelium. This same technology is enabling researchers to examine the thousands of genes in individual lung cancers, which has demonstrated congruence between the histological and clinical presentation (Fong, et al., 2003) ...
Page 26
... respiratory tract. It is accepted that a series of morphological changes occur before lung cancer can be rec- ognized (Ingle, 2000; Andreeff, Goodrich, & Koeffler, 2006). As in most cancers, there are a series of morphological changes ...
... respiratory tract. It is accepted that a series of morphological changes occur before lung cancer can be rec- ognized (Ingle, 2000; Andreeff, Goodrich, & Koeffler, 2006). As in most cancers, there are a series of morphological changes ...
Page 30
... Respiratory Journal, 18(6), 1059–1068. Brashers, V., & Davey, S. (1998). Alternations in pulmonary function. In K. McCance & S. Huether (Eds.), Pathophysiology: The biological basis for disease in adults and children (3rd ed., pp. 1158 ...
... Respiratory Journal, 18(6), 1059–1068. Brashers, V., & Davey, S. (1998). Alternations in pulmonary function. In K. McCance & S. Huether (Eds.), Pathophysiology: The biological basis for disease in adults and children (3rd ed., pp. 1158 ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss